Response to the letter to the editor “18F-FDG-PET/CT indication in patients affected by differentiated thyroid cancer with elevated serum thyroglobulin and negative whole-body scanning after therapy with 131I”

Domenico Albano; Mark Tulchinsky; Francesco Bertagna; Raffaele Giubbini

doi:10.1007/s00259-020-05063-8

Response to the letter to the editor “¹⁸F-FDG-PET/CT indication in patients affected by differentiated thyroid cancer with elevated serum thyroglobulin and negative whole-body scanning after therapy with ¹³¹I”

Domenico Albano, Mark Tulchinsky, Francesco Bertagna, Raffaele Giubbini

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	2952-2953
Number of pages	2
Journal	European Journal of Nuclear Medicine and Molecular Imaging
Volume	47
Issue number	13
DOIs	https://doi.org/10.1007/s00259-020-05063-8
State	Published - Dec 2020

All Science Journal Classification (ASJC) codes

Radiology Nuclear Medicine and imaging

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/s00259-020-05063-8

Cite this

Albano, D., Tulchinsky, M., Bertagna, F., & Giubbini, R. (2020). Response to the letter to the editor “¹⁸F-FDG-PET/CT indication in patients affected by differentiated thyroid cancer with elevated serum thyroglobulin and negative whole-body scanning after therapy with ¹³¹I”. European Journal of Nuclear Medicine and Molecular Imaging, 47(13), 2952-2953. https://doi.org/10.1007/s00259-020-05063-8

Albano, Domenico ; Tulchinsky, Mark ; Bertagna, Francesco et al. / Response to the letter to the editor “¹⁸F-FDG-PET/CT indication in patients affected by differentiated thyroid cancer with elevated serum thyroglobulin and negative whole-body scanning after therapy with ¹³¹I”. In: European Journal of Nuclear Medicine and Molecular Imaging. 2020 ; Vol. 47, No. 13. pp. 2952-2953.

@article{60fbbf0c429b495eb81252b711cc3184,

title = "Response to the letter to the editor “18F-FDG-PET/CT indication in patients affected by differentiated thyroid cancer with elevated serum thyroglobulin and negative whole-body scanning after therapy with 131I”",

author = "Domenico Albano and Mark Tulchinsky and Francesco Bertagna and Raffaele Giubbini",

year = "2020",

month = dec,

doi = "10.1007/s00259-020-05063-8",

language = "English (US)",

volume = "47",

pages = "2952--2953",

journal = "European Journal of Nuclear Medicine and Molecular Imaging",

issn = "1619-7070",

publisher = "Springer Verlag",

number = "13",

}

Albano, D, Tulchinsky, M, Bertagna, F & Giubbini, R 2020, 'Response to the letter to the editor “¹⁸F-FDG-PET/CT indication in patients affected by differentiated thyroid cancer with elevated serum thyroglobulin and negative whole-body scanning after therapy with ¹³¹I”', European Journal of Nuclear Medicine and Molecular Imaging, vol. 47, no. 13, pp. 2952-2953. https://doi.org/10.1007/s00259-020-05063-8

Response to the letter to the editor “¹⁸F-FDG-PET/CT indication in patients affected by differentiated thyroid cancer with elevated serum thyroglobulin and negative whole-body scanning after therapy with ¹³¹I”. / Albano, Domenico; Tulchinsky, Mark; Bertagna, Francesco et al.
In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 47, No. 13, 12.2020, p. 2952-2953.

Research output: Contribution to journal › Letter › peer-review

TY - JOUR

T1 - Response to the letter to the editor “18F-FDG-PET/CT indication in patients affected by differentiated thyroid cancer with elevated serum thyroglobulin and negative whole-body scanning after therapy with 131I”

AU - Albano, Domenico

AU - Tulchinsky, Mark

AU - Bertagna, Francesco

AU - Giubbini, Raffaele

PY - 2020/12

Y1 - 2020/12

UR - http://www.scopus.com/inward/record.url?scp=85092076685&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85092076685&partnerID=8YFLogxK

U2 - 10.1007/s00259-020-05063-8

DO - 10.1007/s00259-020-05063-8

M3 - Letter

C2 - 33025094

AN - SCOPUS:85092076685

SN - 1619-7070

VL - 47

SP - 2952

EP - 2953

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

IS - 13

ER -